Reg. 34 (1) Annual Report.
Filed with BSE · · 71 pages · English
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Scheme of Arrangement
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 25 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals